Pharmacokinetics of intravenous azithromycin and ceftriaxone when administered alone and concurrently to healthy volunteers

J Antimicrob Chemother. 2002 Dec;50(6):1075-9. doi: 10.1093/jac/dkg003.


This study was conducted to identify whether or not a pharmacokinetic interaction existed when azithromycin and ceftriaxone were administered concurrently. This randomized, open-label, three-way crossover study in 12 healthy volunteers characterized the plasma pharmacokinetic parameter profiles of both drugs, as well as the white blood cell uptake and exposure to azithromycin, when the drugs were administered alone and together. The plasma pharmacokinetic parameters for azithromycin and ceftriaxone did not differ significantly either after a single dose or at steady state when the two were co-administered as opposed to being administered alone. Moreover, the neutrophil and monocyte/lymphocyte peak azithromycin concentrations and sampling period exposures also did not differ significantly between the study arm and the control arm. This study confirms that there is no interaction between azithromycin and ceftriaxone when they are administered concurrently.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Area Under Curve
  • Azithromycin / administration & dosage
  • Azithromycin / pharmacokinetics*
  • Ceftriaxone / administration & dosage
  • Ceftriaxone / pharmacokinetics*
  • Cross-Over Studies
  • Drug Therapy, Combination / administration & dosage
  • Drug Therapy, Combination / pharmacokinetics*
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged


  • Ceftriaxone
  • Azithromycin